SCHEMBL4757200

SCHEMBL4757200

Cc1cc(Cl)c(C(=O)Nc2ncc(S(C)(=O)=O)s2)cc1Cl

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FFAR2 O15552 1/20 0.47
GPR27 Q9NS67 2/20 0.43
GRM4 Q14833 3/20 0.41
AHR P35869 1/20 0.39
NPC1 O15118 4/20 0.38
RAB9A P51151 4/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
POLB P06746 1/20 0.38
ALDH1A1 P00352 2/20 0.38
BLM P54132 1/20 0.38
LMNA P02545 1/20 0.38
LCK P06239 1/20 0.37
PKM P14618 1/20 0.37
RXFP1 Q9HBX9 2/20 0.37
KDM4E B2RXH2 1/20 0.37
CRHBP P24387 1/20 0.37
CRHR2 Q13324 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4757204 0.90 FFAR2 (0.44) FFAR2GRM4AHRNPC1RAB9A
SCHEMBL4756645 0.86 NPC1 (0.41) FFAR2GRM4AHRNPC1RAB9A
SCHEMBL4757189 0.84 FFAR2 (0.48) FFAR2GPR27GRM4NPC1RAB9A
SCHEMBL10114566 0.83 ALDH1A1 (0.45) FFAR2GRM4AHRNPC1RAB9A
SCHEMBL4756947 0.81 FFAR2 (0.47) FFAR2GRM4NPC1RAB9AMEN1
SCHEMBL4756975 0.80 FFAR2 (0.48) FFAR2GRM4AHRNPC1RAB9A
SCHEMBL4756965 0.80 FFAR2 (0.48) FFAR2GRM4NPC1RAB9AMEN1
SCHEMBL4757157 0.79 STAT3 (0.49) FFAR2GPR27NPC1RAB9AMEN1
SCHEMBL4757105 0.78 FFAR2 (0.44) FFAR2NPC1RAB9AMEN1KMT2A
SCHEMBL10114555 0.78 FFAR2 (0.44) FFAR2GPR27GRM4NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC FFAR2 4045/4885GPR27 3162/4885GRM4 4380/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.